Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 780 3rd Ave, New York,ny 10017,united States
- Industry
- Biotechnology
- Website
- http://www.stelexis.com
- Keywords
- Cancer Therapeutics, Drug Discovery, New York.
- HQ
- New York, NY
Stelexis Biosciences, Inc. Questions
Stelexis Biosciences, Inc.'s website is http://www.stelexis.com
Stelexis Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/stelexis-biosciences
Stelexis Biosciences, Inc. has
15 employees.
View email and phone details for 15
employees at Stelexis Biosciences, Inc..
Stelexis Biosciences, Inc.'s industry is
Biotechnology
Stelexis Biosciences, Inc.'s top competitors are
Concarlo Therapeutics,
Chimerna Therapeutics,
Clin Street,
Dracen Pharmaceuticals, Inc.,
Olatec Therapeutics,
Realize Therapeutics,
Oncusp Therapeutics,
Indaptus Therapeutics, Inc.,
Eliksa Therapeutics,
Fekra Therapeutics.
Stelexis Biosciences, Inc.'s categories are Biotechnology
Stelexis Biosciences, Inc.'s founding year is 2017
